covid
Buscar en
Gaceta Médica de Bilbao
Toda la web
Inicio Gaceta Médica de Bilbao S1.1 Etiopatogenia del liquen plano oral
Información de la revista
Vol. 98. Núm. 4.
Páginas 93-95 (enero 2001)
Compartir
Compartir
Descargar PDF
Más opciones de artículo
Vol. 98. Núm. 4.
Páginas 93-95 (enero 2001)
Acceso a texto completo
S1.1 Etiopatogenia del liquen plano oral
S1.1 The etiopathogenesis of oral lichen planus
Visitas
3207
S. Zunt
Universidad de Indiana. Indiana. USA
Este artículo ha recibido
Información del artículo
El Texto completo está disponible en PDF
References
[1.]
Axell T., Rundquist L..
Oral lichen planus—a demographic study.
Comm Dent Oral Epidemiol, 15 (1987), pp. 52-56
[2.]
Silverman S. Jr, Gorsky M..
A prospective study of findings and management in 214 patients with oral lichen planus.
Oral Surg Oral Med Oral Pathol, 72 (1985), pp. 665-670
[3.]
Walsh L.J., Savage N.W., Ishii T., Seymour G.I..
Immunopathogenenesis of oral lichen planus.
J Oral Pathol Med, 19 (1990), pp. 389-396
[4.]
Challacombe S.J., Shirlow P.J., et al.
Immunology of Diseases of the Oral Cavity. Chapter in Mucosal Immunity, Second,
[5.]
Burkhardt N.W., Burker E.J., Burkes E.J., Wolfe L..
Assessing the characteristics of patients with oral lichen planus.
JADA, 127 (1996), pp. 648-662
[6.]
Scully C., El-Kom M..
Lichen planus: review and update on pathogenesis.
J Oral Pathol, 14 (1985), pp. 431-458
[7.]
Thomas D.W., Stephens P., Stephens M., Patten D.W., Lim S.H..
T-cell receptor V beta usage by lesional lymphocytes in oral lichen planus.
J Oral Pathol Med, 26 (1997), pp. 105-109
[8.]
Carrozzo M., Gandolfo S..
The management of oral lichen planus.
Oral Dis, 5 (1999), pp. 196-205
[9.]
Eisen D..
The therapy of oral lichen planus.
Crit Rev Oral Biol Med, 4 (1993), pp. 141-158
[10.]
Epstein J.B., Gorsky M., Epstein M.S., Nantel S..
Topical azathioprine in the treatment of immune-mediated chronic oral inflammatory conditions.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 91 (2001), pp. 56-61
[11.]
Lener E.V., Brieva J., Schachter M., West L.E., West D.P., el-Azhary R.A..
Successful treatment of erosive lichen planus with topical tacrolimus.
Arch Dermatol, 137 (2001), pp. 419-422
[12.]
Cribier B., Frances C., Chosidow O..
Treatment of lichen planus.
An evidence-based medicine analysis of efficacy. Arch Dermatol, 134 (1998), pp. 1521-1530
[13.]
Farthing P.M., Matear P., Cruchley A.T..
The activation of Langerhans cells in oral lichen planus.
J Oral Pathol Med, 19 (1990), pp. 81-85
[14.]
Regezi J.A., Stewart J.C., Lloyd R.V., Headington J.J..
Immunohistochemical staining of Langerhans and macrophages in oral lichen planus.
Oral Surg Oral Med Oral Pathol, 60 (1985), pp. 396-402
[15.]
Regezi J.A., Daniels T.E., Saeb F., Nickoloff B.J..
Increased submucosal factor XIIIa-positive dendrocytes in oral lichen planus.
J Oral Pathol Med, 23 (1994), pp. 14-18
[16.]
Pemberton M.N., Sloan P., Thakker N.S..
Oral lichenoid lesions after hepatitis B vaccination.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 89 (2000), pp. 717-719
[17.]
Halvey S., Shai A..
Lichenoid drug eruptions.
J Am Acad Dermatol, 29 (1993), pp. 249-255
[18.]
Chiappelli F., Kung M.A., Nygyen P., Villaneuva P., Arash Farhadian E., Evesole L.R..
Cellular immune correlates of clinical severity in oral lichen planus: preliminary association with mood stress.
Oral Diseases, 3 (1997), pp. 64-70
[19.]
Watanabe T., Ohishi M., Tanaka K., Sato H..
Analysis of HLA antigens in Japanese with oral lichen planus and lichenoid reactions.
J Oral Pathol, 15 (1986), pp. 429-433
[20.]
Lin S.C., Sun A..
HLA-DR and DQ antigens in Chinese patients with oral lichen planus.
J Oral Pathol Med, 19 (1990), pp. 298-300
[21.]
DePanfilis G., Manara G., Sansoni P., Allegra F..
T-cell infiltrate in lichen planus.
Demonstration of activated lymphocytes using monoclonal antibodies. J Cutan Pathol, 10 (1983), pp. 52-58
[22.]
Zhou X.J., Savage N.W., Sugerman P.B., Walsh L.H., Aldred M.J., Seymour G.J..
TRC V beta gene expression in lesional T lymphocyte lines in oral lichen planus.
Oral Diseases., (1996), pp. 295-298
[23.]
Thomas D.W., Stephens P., Stephens M., Patten D.W., Lim S.H..
T-cell receptor V beta usage by lesional lymphocytes in oral lichen planus.
J Oral Pathol Med, 26 (1997), pp. 105-109
[24.]
Regezi J.A., Dekker N.P., MacPhail L.A., Lozada-Nur F., McCalmont T.H..
Vascular adnesion molecules in oral lichen planus.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 81 (1996), pp. 682-690
[25.]
Chaiyarit P., Kawfrawy A.H., Miles D.A., Zunt S.L., Van Dis M.L., Gregory R.L..
Oral lichen planus: an immunohistochemical study of heat shock proteins (HSPs) and cytokeratins (CKs) and a unifying hypothesis of pathogenesis.
J Oral Pathol Med., 28 (1999), pp. 210-215
[26.]
Bramanti T.E., Dekker N.P., Lozada-Nur F., Sauk J.S., Regezi J.A..
Heatshock (stress) proteins and gamma/delta T lymphocytes in oral lichen planus.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 80 (1995), pp. 698-704
[27.]
Health Organization Collaborating Centre for Oral Precancerous Lesions.
Definition of leukoplakia and related lesions: an aid to studies on oral precancer.
Oral Surg Oral Med Oral Pathol, 46 (1978), pp. 518-539
[28.]
Krutchkoff D.J., Eisenberg E..
Lichenoid dysplasia: a distinct histopathologic entity.
Oral Surg Oral Med Oral Pathol, 60 (1985), pp. 308-315
[29.]
van der Meij R.H., Reibel J., van der Wal J.E., de Jong W.F.B., van der Waal I..
Interobserver and intraobserver variability in the histologic assessment of oral lichen planus.
J Oral Pathol Med, 28 (1999), pp. 247-274
[30.]
Firth N.A., Rich A.M., Radden B.G., Reade P.C..
Assessment of the value of immunofluorescence microscopy in the diagnosis of oral mucosal lichen planus.
J Oral Pathol Med, 19 (1990), pp. 295-297
[31.]
Rodriguez-Nunez I., Blanco-Carrion A., Garcia A.G., Gámdara Rey J.G..
Peripheral T-cell subsets in patients with reticular and atrophic-erosive oral lichen planus.
Oral Surg Oral Med Oral Pathol Oral Radio Endod, 91 (2001), pp. 180-188
[32.]
Laine J., Konttinen Y.T., Beliaev N., Happonen R-P.
Immunocompetent cells in amalgam-associated oral lichenoid contact lesions.
J Oral Pathol Med, 28 (1999), pp. 117-121
[33.]
Lamey P-J, McCartan B.E., MacDonald D.G., MacKie R.M..
Basal cell cytoplasmic autoantibodies in oral lichenoid reactions, 79 (1995), pp. 44-49
[34.]
McQueen A., Behan W.M..
Immunofluorescence microscopy: the “string of pearls” phenomenon and immunofluorescent serological finding in patients screened for adverse drug reactions.
Am J Dermatopathol, 4 (1982), pp. 155-159
[35.]
Potts A.J.C., Hamburger J., Scully C..
The medication of patients with oral lichen planus and the association of nonsteroidal anti-inflammatory drugs with erosive lesions.
Oral Surg Oral Med Oral Pathol, 64 (1987), pp. 541-543
[36.]
Ingafou M., Lodi G., Olsen I., Porter S.R..
Oral lichen planus is not associated with IgG circulating antibodies to epithelial antigens.
Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 84 (1997), pp. 175-178
[38.]
Porter S.R., Kirby A., Olsen I., Barrett W..
Immunologic aspects of dermal and oral lichen planus.
A review. Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 83 (1997), pp. 358-366
[39.]
Boyd A.S., Heldner K.H..
Lichen planus.
J Am Acad Dermatol, 25 (1991), pp. 593-619
[40.]
Scully C., Beyli M., Ferreiro M.C., Ficarra G., Gill Y., Griffiths M., Holmstrup P., Mutlu S., Porter S., Wray D..
Update on oral lichen planus Etiopathogenesis and management.
Crit Rev Oral Biol Med, 9 (1998), pp. 822-861
[41.]
Mignogna M.D., Muzio L.L., Russo L.L., Fedele S., Ruoppo E., Bucci E..
Clinical guidelines in early detection of oral squamous cell carcinoma arising in oral lichen planus: a 5 year experience.
Oral Oncology, 37 (2001), pp. 262-267
Copyright © 2001. Academia de Ciencias Médicas de Bilbao
Opciones de artículo